Search - tctmd.com

Displaying 141 - 160 of 4560

Sort: Relevancy | Date

Presentation TCT 2016

Bifurcation/Left Main Stents IV: Nile

Presenter: Chaim S. Lotan, Giora Weisz, Ivo Petrov

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents III: Bioss

Presenter: Chaim S. Lotan, Giora Weisz, Robert J. Gil

October 31, 2016

Presentation TCT 2016

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Presenter: Thomas F. Luscher, Patrick W. Serruys, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Li Zhi

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents II: Axxess

Presenter: Chaim S. Lotan, Giora Weisz, Christophe Dubois

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents I: Tryton

Presenter: Chaim S. Lotan, Giora Weisz, Philippe Généreux

October 31, 2016

Presentation TCT 2016

DISRUPT CAD: A multicenter, prospective, single-arm study of percutaneous lithoplasty prior to stent implantation in heavily calcified coronary lesions

Presenter: Joseph A. Hill, Steven P. Marso, Todd J. Brinton

October 31, 2016

Presentation TCT 2016

Dedicated Stents for Specific Scenarios: Historical Perspectives and Stuttering Progress

Presenter: Chaim S. Lotan, Giora Weisz, Martin B. Leon

October 31, 2016

Presentation TCT 2016

TCT 19: Vascular Response to Paclitaxiel-Eluting Nitinol Self-Expanding Stent in Superficial Femoral Artery Lesions: Angioscopic Findings at Two, Six, and Twelve Months After Implantation

Presenter: Sriram S. Iyer, Craig M. Walker, Toshiro Shinke

October 31, 2016

News Industry News

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

October 31, 2016

Presentation TCT 2016

B Braun - ISAR Coroflex

Presenter: Marie-Claude Morice, Christian Hengstenberg

October 31, 2016

Presentation TCT 2016

FAME I and FAME II: Predictive Value of Fractional Flow Reserve After Drug-Eluting Stent Implantation

Presenter: Spencer B. King III, Jagat Narula, Zsolt Piroth

October 31, 2016

Presentation TCT 2016

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

Presentation TCT 2016

Alvimedica - Cre8: Design Specifications and Results

Presenter: Marie-Claude Morice, Gennaro Sardella

October 31, 2016

Presentation TCT 2016

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Presenter: Marie-Claude Morice, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Medtronic Drug-Filled Stent: 6-Month Results From Revelution

Presenter: Marie-Claude Morice, Stephen G. Worthley

October 31, 2016

Presentation TCT 2016

TCT 442: 3-Year Clinical Outcomes of Complete Versus Partial Stent Fracture After Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stent

Presenter: Nicolas Foin, Giampaolo Niccoli

October 31, 2016

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

Presentation TCT 2016

TCT 317: Ten-Year Impact of Stent Fracture and Peri-Stent Contrast staining After Sirolimus-Eluting Stent Implantation on Target Lesion Revascularization

Presenter: Nicolas Foin, Giampaolo Niccoli

October 31, 2016

Advertisement

Bifurcation/Left Main Stents IV: Nile

Bifurcation/Left Main Stents III: Bioss

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Bifurcation/Left Main Stents II: Axxess

Bifurcation/Left Main Stents I: Tryton

DISRUPT CAD: A multicenter, prospective, single-arm study of percutaneous lithoplasty prior to stent implantation in heavily calcified coronary lesions

Dedicated Stents for Specific Scenarios: Historical Perspectives and Stuttering Progress

TCT 19: Vascular Response to Paclitaxiel-Eluting Nitinol Self-Expanding Stent in Superficial Femoral Artery Lesions: Angioscopic Findings at Two, Six, and Twelve Months After Implantation

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

B Braun - ISAR Coroflex

FAME I and FAME II: Predictive Value of Fractional Flow Reserve After Drug-Eluting Stent Implantation

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Alvimedica - Cre8: Design Specifications and Results

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Medtronic Drug-Filled Stent: 6-Month Results From Revelution

TCT 442: 3-Year Clinical Outcomes of Complete Versus Partial Stent Fracture After Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stent

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

TCT 317: Ten-Year Impact of Stent Fracture and Peri-Stent Contrast staining After Sirolimus-Eluting Stent Implantation on Target Lesion Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content